Guérin E - Search Results

1

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.

Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. Reita D, et al. Among authors: guerin e. Cancers (Basel). 2021 Sep 30;13(19):4926. doi: 10.3390/cancers13194926. Cancers (Basel). 2021. PMID: 34638411 Free PMC article. Review.

2

Use of magnetic beads for plasma cell-free DNA extraction: toward automation of plasma DNA analysis for molecular diagnostics.

Stemmer C, Beau-Faller M, Pencreac'h E, Guerin E, Schneider A, Jaqmin D, Quoix E, Gaub MP, Oudet P. Stemmer C, et al. Among authors: guerin e. Clin Chem. 2003 Nov;49(11):1953-5. doi: 10.1373/clinchem.2003.020750. Clin Chem. 2003. PMID: 14578335 No abstract available.

3

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression.

Beau-Faller M, Gaub MP, Schneider A, Guérin E, Meyer N, Ducrocq X, Massard G, Gasser B, Kessler R, Weitzenblum E, Wihlm JM, Quoix E, Oudet P. Beau-Faller M, et al. Among authors: guerin e. Eur J Cancer. 2003 Nov;39(17):2538-47. doi: 10.1016/s0959-8049(03)00623-3. Eur J Cancer. 2003. PMID: 14602140

4

MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.

Beau-Faller M, Ruppert AM, Voegeli AC, Neuville A, Meyer N, Guerin E, Legrain M, Mennecier B, Wihlm JM, Massard G, Quoix E, Oudet P, Gaub MP. Beau-Faller M, et al. Among authors: guerin e. J Thorac Oncol. 2008 Apr;3(4):331-9. doi: 10.1097/JTO.0b013e318168d9d4. J Thorac Oncol. 2008. PMID: 18379349 Free article.

5

EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up.

Ruppert AM, Beau-Faller M, Neuville A, Guerin E, Voegeli AC, Mennecier B, Legrain M, Molard A, Jeung MY, Gaub MP, Oudet P, Quoix E. Ruppert AM, et al. Among authors: guerin e. Eur Respir J. 2009 Feb;33(2):436-40. doi: 10.1183/09031936.00162307. Eur Respir J. 2009. PMID: 19181917 Free article.

6

Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.

Pencreach E, Guérin E, Nicolet C, Lelong-Rebel I, Voegeli AC, Oudet P, Larsen AK, Gaub MP, Guenot D. Pencreach E, et al. Among authors: guerin e. Clin Cancer Res. 2009 Feb 15;15(4):1297-307. doi: 10.1158/1078-0432.CCR-08-0889. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190131

7

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping.

Beau-Faller M, Legrain M, Voegeli AC, Guérin E, Lavaux T, Ruppert AM, Neuville A, Massard G, Wihlm JM, Quoix E, Oudet P, Gaub MP. Beau-Faller M, et al. Among authors: guerin e. Br J Cancer. 2009 Mar 24;100(6):985-92. doi: 10.1038/sj.bjc.6604925. Br J Cancer. 2009. PMID: 19293811 Free PMC article.

8

A cytogenetic study of 397 consecutive acute myeloid leukemia cases identified three with a t(7;21) associated with 5q abnormalities and exhibiting similar clinical and biological features, suggesting a new, rare acute myeloid leukemia entity.

Jeandidier E, Gervais C, Radford-Weiss I, Zink E, Gangneux C, Eischen A, Galoisy AC, Helias C, Dano L, Cammarata O, Jung G, Harzallah I, Guérin E, Martzolff L, Drénou B, Lioure B, Tancrédi C, Rimelen V, Mauvieux L. Jeandidier E, et al. Among authors: guerin e. Cancer Genet. 2012 Jul-Aug;205(7-8):365-72. doi: 10.1016/j.cancergen.2012.04.007. Cancer Genet. 2012. PMID: 22867997

9

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse.

Nguyen A, Lasthaus C, Guerin E, Marcellin L, Pencreach E, Gaub MP, Guenot D, Entz-Werle N. Nguyen A, et al. Among authors: guerin e. Cancers (Basel). 2013 Jun 4;5(2):662-75. doi: 10.3390/cancers5020662. Cancers (Basel). 2013. PMID: 24216996 Free PMC article.

10

Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients.

Prim N, Legrain M, Guerin E, Mennecier B, Weingertner N, Voegeli AC, Guenot D, Maugard CM, Quoix AE, Beau-Faller M. Prim N, et al. Among authors: guerin e. Eur Respir Rev. 2014 Sep;23(133):390-2. doi: 10.1183/09059180.00009313. Eur Respir Rev. 2014. PMID: 25176975 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page